Biocon Biologics completes integration of Viatris Biosimilars’ Business in North America
With the completion of the North America integration, the existing commercialised portfolio of biosimilars, Ogiviri…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Insulin glargine
Biocon Biologics and Viatris launch interchangeable Semglee
Branded and unbranded versions of the first-ever interchangeable biosimilar in the US provide more affordable options for the…
Biocon Biologics and Viatris’s Semglee preferred on Express Scripts’ largest formulary in US
Express Scripts, a leading pharmacy benefit management organisation, will list Viatris-labelled biosimilar Insulin Glargine as a…
Inter-changeable designation for Semglee in the US is a milestone achievement for Biocon Biologics
Dr Arun Chandavarkar, Managing Director, Biocon Biologics talks to Akanki Sharma about his role and vision for the company, while…
Biocon Biologics to offer its Oncology Biosimilars through Cancer Access Partnership in over 30…
Biocon Biologics, a subsidiary of
Biocon has signed an agreement with the Clinton Health Access Initiative (CHAI) to expand…
Biocon and Voluntis deal to transform insulin biosimilars personalised care through digital…
By the end of March 2020, Semglee was approved in 60 countries and launched in several countries including the EU, Australia and…
Biocon Biologics receives EU GMP Certification for multiple Biosimilars manufacturing facilities in…
These facilities are used for the manufacture of DS and DP for Biosimilars: Bevacizumab, Trastuzumab, Pegfilgrastim and secondary…
Biocon, Mylan win patent litigation for Insulin Glargine device patent in the US
Brings Biocon closer to commercialising Semglee in the US in 2020 Biocon has won a US court ruling that invalidated a Sanofi…
Biocon gets three observations from US health regulator for Malaysia facility
The FDA has set a target action date for its insulin glargine application in June 2020
Biocon’s Malaysia Insulin glargine facility receives Certificate of GMP
The approval expands Biocon’s capacities, with new large scale devices facility coming up to speed to serve growing needs of…